Basit öğe kaydını göster

dc.contributor.authorGoker, Burcu
dc.contributor.authorCan, Halil
dc.contributor.authorDolgun, Muge
dc.contributor.authorSencer, Altay
dc.contributor.authorAydoseli, Aydin
dc.contributor.authorGomleksiz, Cengiz
dc.contributor.authorAltunrende, Muhittin Emre
dc.date.accessioned2021-03-05T22:02:42Z
dc.date.available2021-03-05T22:02:42Z
dc.date.issued2017
dc.identifier.citationCan H., Aydoseli A., Gomleksiz C., Goker B., Altunrende M. E. , Dolgun M., Sencer A., "Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury", ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, cilt.23, ss.452-458, 2017
dc.identifier.issn1306-696X
dc.identifier.otherav_dbc86d95-7a8f-4ac8-8bba-af56c1c2e361
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144854
dc.identifier.urihttps://doi.org/10.5505/tjtes.2017.09694
dc.description.abstractBACKGROUND: We investigated the effects of an N-methyl-D-aspartate receptor antagonist, riluzole, and a pancaspase inhibitor and basic apoptosis mediator, Q-VD-OPh, in combination or alone in posttraumatic spinal cord injury.
dc.language.isoeng
dc.subjectAcil Tıp
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectACİL TIP
dc.titleCombined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury
dc.typeMakale
dc.relation.journalULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY
dc.contributor.departmentMed Hosp , ,
dc.identifier.volume23
dc.identifier.issue6
dc.identifier.startpage452
dc.identifier.endpage458
dc.contributor.firstauthorID247368


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster